Aleksandar Krstić

GSK3 Inhibitors Regulate <i>MYCN</i> mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling

David J. Duffy, Aleksandar Krstić, Thomas Schwarzl et al. · Molecular Cancer Therapeutics · 2013 · 82 citations · Full text

Multiple Mechanisms, Neuroblastoma Cell Viability, Pathology +17

Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS Signaling

Oleksii S. Rukhlenko, Fahimeh Khorsand, Aleksandar Krstić et al. · Cell Systems · 2018 · 73 citations · Full text

Drug Target, Signal Transduction, Signaling Pathway +10

Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D

Susan Kennedy, Mohamed Ali Jarboui, Sriganesh Srihari et al. · Nature Communications · 2020 · 71 citations · Full text

PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359

Javier Rodríguez, Ana Herrero, Shuijie Li et al. · Cell Reports · 2018 · 63 citations · Full text

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma

David J. Duffy, Aleksandar Krstić, Melinda Halász et al. · Oncotarget · 2015 · 46 citations · Full text